Generic alternative for brain tumor treatment

Israel’s Teva has partnered with the US/Israeli firm Perrigo to launch “a high quality, less expensive alternative” to Temodar (temozolomide) for the treatment of adult patients with newly diagnosed glioblastoma multiforme (brain tumor). Teva also had good news about its chemotherapy and prostate cancer treatments.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *